1ZTS:BIT
Zoetis Inc
61,60 €
arrow_downward
-0,93%(-0,58) 1D
2 ოქტ, 17:26:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Kalkine Media
·
5 საათის წინ
Zoetis EVP Rimma Driscoll Acquires 277.77 Phantom Stock Units via Supplemental Savings Plan
Stock Titan
·
5 საათის წინ
An EVP acquires 321.4945 cash-settled stock-linked units at Zoetis (ZTS).
TipRanks
·
9 საათის წინ
Zoetis Stock Slips As Board Shake-Up Disappoints
Yahoo Finance
·
14 საათის წინ
Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia